They have been shown to increase MM cell survival and protection from drug-induced apoptosis via contact-dependent interaction with MM PCs, involving PSGL-1 and ICAM-1 on MM PCs and E- and P-selectins and CD18 on the cell surface of macrophages (65–67). The gene discussed is ITGB2; the disease is Miyoshi myopathy.